Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

2010 ◽  
Vol 11 (1) ◽  
pp. 38-47 ◽  
Author(s):  
Gunnar Folprecht ◽  
Thomas Gruenberger ◽  
Wolf O Bechstein ◽  
Hans-Rudolf Raab ◽  
Florian Lordick ◽  
...  
Keyword(s):  
Neoadjuvant Chemotherapy ◽  
Liver Metastases ◽  
Colorectal Liver Metastases ◽  
Tumour Response ◽  
Phase 2 ◽  
Phase 2 Trial ◽  
Secondary Resectability

Survival benefit of neoadjuvant chemotherapy and surgery versus surgery first for resectable colorectal liver metastases: a cohort study

2021 ◽  
Author(s):  
Corina Behrenbruch ◽  
Sowmya Prabhakaran ◽  
Dilshan Udayasiri ◽  
Frédéric Hollande ◽  
Michael Michael ◽  
...  
Keyword(s):  
Cohort Study ◽  
Neoadjuvant Chemotherapy ◽  
Liver Metastases ◽  
Survival Benefit ◽  
Colorectal Liver Metastases ◽  
Surgery First

The pathological response to neoadjuvant chemotherapy with FOLFOX-4 for colorectal liver metastases: a comparative study

2007 ◽  
Vol 451 (5) ◽  
pp. 943-948 ◽  
Author(s):  
Mark M. Aloysius ◽  
Abed M. Zaitoun ◽  
Ian J. Beckingham ◽  
Keith R. Neal ◽  
Guruprasad P. Aithal ◽  
...  
Keyword(s):  
Neoadjuvant Chemotherapy ◽  
Comparative Study ◽  
Liver Metastases ◽  
Colorectal Liver Metastases ◽  
Pathological Response ◽  
Response To Neoadjuvant Chemotherapy

scholarly journals Impact of Neoadjuvant Chemotherapy on Clinical Risk Scores and Survival in Patients with Colorectal Liver Metastases

2016 ◽  
Vol 24 (1) ◽  
pp. 236-243 ◽  
Author(s):  
Kerstin Wimmer ◽  
Christoph Schwarz ◽  
Carmen Szabo ◽  
Martin Bodingbauer ◽  
Dietmar Tamandl ◽  
...  
Keyword(s):  
Neoadjuvant Chemotherapy ◽  
Liver Metastases ◽  
Colorectal Liver Metastases ◽  
Risk Scores ◽  
Clinical Risk
Sign in / Sign up

Export Citation Format

Share Document